In Brief: Immunomedics' CEA-Scan
This article was originally published in The Gray Sheet
Executive Summary
Lilly will distribute the colorectal cancer imaging agent in Europe after Immunomedics terminates its 1995 and 1996 marketing and distribution arrangements with Mallinckrodt for the U.S. and Europe. A new distributor for the U.S. will be announced soon, the Morris Plains, New Jersey-based company says. Immunomedics is pursuing a different strategy to promote the product, which requires a "focused effort to educate and train both oncologists and nuclear physicians," the company says...